[ Price : $8.95]
FDAs recent rejection of an experimental melanoma treatment becomes a flashpoint in broader criticism of former FDA commissioner M...[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially high-risk problem involving certain anesthesia workstat...[ Price : $8.95]
FDA approves Genentechs Tecentriq (atezolizumab) and a subcutaneous formulation of the drug for the adjuvant treatment of certain ...[ Price : $8.95]
FDA says Sun Pharma has recalled one batch of doxorubicin HCl liposome injection due to glass particles found in some vials during...[ Price : $8.95]
University of Missouri law professor Erika Lietzan says FDA may not suffer as much under the Supreme Courts Loper Bright decision ...[ Price : $8.95]
CDER publishes a Manual of Policies and Procedures on approaches for assessing drug substance and drug product impurity acceptance...[ Price : $8.95]
FDA commissioner Marty Makarys resignation capped one of the shortest and most turbulent FDA tenures in recent memory, with media ...[ Price : $8.95]
AstraZeneca reports positive data in a trial evaluating perioperative treatment with Imfinzi (durvalumab) combined with neoadjuvan...